Sort
21,453 grants matching “tuberculosis”
Using the Mycobacterium tuberculosis Genome to Predict Tuberculosis Pathology, Drug Resistance Acquisition and Identify Community Transmission Sites
$651,979Robert H Gilman · Johns Hopkins University · R01 · FY2023 · AI
Development of therapeutic chemokine-based formulations
$651,880Bira Arya · National Institute On Aging · ZIA · FY2015 · AG
INNOVATIVE APPROACHES TO TUBERCULOSIS CONTROL
$651,816Johns Hopkins University · U19 · FY2003 · AI
Therapeutics for drug-resistant bacteria: aryl myxopyronins and arylalkylcarboxamido phloroglucinols
$651,550Richard H. Ebright · Hackensack University Medical Center · U19 · FY2023 · AI
Development of novel anti-TB drugs that inhibit cell wall biosynthesis and respiration
$651,550David Alland · Hackensack University Medical Center · U19 · FY2022 · AI
Therapeutics for drug-resistant bacteria: aryl myxopyronins and arylalkylcarboxamido phloroglucinols
$651,550Richard H. Ebright · Hackensack University Medical Center · U19 · FY2022 · AI
Host determinants of protection against tuberculosis in adolescents
$651,532Thomas Jens Scriba · University Of Cape Town · R01 · FY2014 · AI
Gene Regulation In The Immune System
$651,474Keiko Ozato · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIH · FY2017 · HD
Rapid Immune Restoration and Lung Injury in HIV/TB
$651,351Gregory P. Bisson · University Of Pennsylvania · R01 · FY2015 · AI
Novel non-invasive antigen detection assay for the diagnosis of active visceral leishmaniasis and to monitor the therapy efficacy of this disease
$651,346Claudia Abeijon · Detectogen, Inc. · R44 · FY2019 · AI
A TB Vaccine for AIDS Patients
$651,218Marcus Aaron Horwitz · University Of California Los Angeles · R01 · FY2007 · AI
Mechanism Based Inhibition of M Tuberculosis Enzymes
$651,113John S Blanchard · Albert Einstein College Of Medicine · R01 · FY2008 · AI
Quit4Life+: Adapting and Evaluating a Phone-Based Tobacco Use Cessation Program for People Living with HIV in Uganda and Zambia
$651,101Heather L Wipfli · University Of Southern California · U01 · FY2024 · CA
PROJECT 2: Determine clinically relevant host-viral dependency networks for respiratory infections including SARS-CoV-2
$651,020Melanie Maria Ott · University Of California, San Francisco · U19 · FY2025 · AI
Proteogenomics of dysregulated protein interaction networks in MTB infection
$650,954W. Henry Henry Boom · Case Western Reserve University · R01 · FY2013 · HL
Aerobiology, immunology, and Mycobacterium tuberculosis transmission
$650,953David J. Horne · University Of Washington · R01 · FY2024 · AI
Genetics & Clinical Cohorts
$650,631Sarah Jane Dunstan · University Of Washington · U19 · FY2024 · AI
Biocontainment Research support services core
$650,619Farhang Alem · George Mason University · UC7 · FY2025 · AI
Heme and hemoglobin utilization by Mycobacterium tuberculosis
$650,548Michael Niederweis · University Of Alabama At Birmingham · R01 · FY2021 · AI
Using the Mycobacterium tuberculosis Genome to Predict Tuberculosis Pathology, Drug Resistance Acquisition and Identify Community Transmission Sites
$650,548Robert H Gilman · Johns Hopkins University · R01 · FY2022 · AI
Novel Reporter Phages to Detect Complex TB Drug Resistance and Persistence
$650,498Michelle H Larsen · Albert Einstein College Of Medicine, Inc · R01 · FY2016 · AI
Targeting Hsp90 in cryptococcal fungal pathogenesis
$650,345Leah Elizabeth Cowen · University Of Toronto · R01 · FY2025 · AI
Project 1 - Exploiting Metabolic Vulnerabilities
$650,284Christopher M Sassetti · Texas A&M Agrilife Research · P01 · FY2020 · AI
Immune correlates of LTBI in HIV-exposed infants
$650,269Savita Pahwa · University Of Miami School Of Medicine · R01 · FY2019 · AI
Role of mycobacterial dynamin-like proteins in the biogenesis of membrane vesicles, and host-pathogen interactions
$650,180Gloria Marcela Rodriguez · Rutgers Biomedical And Health Sciences · R01 · FY2023 · AI